Plain-English translation of NCT06757309 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The VIHMET study is testing whether switching to a Mediterranean diet—rich in whole foods, healthy fats, and lean proteins—can improve heart health and reduce harmful inflammation in people living with HIV. People with HIV face higher risks of heart disease and ongoing immune activation, even when their virus is well-controlled by medication. This trial will see if dietary changes alone can make a real difference.
People living with HIV have higher rates of heart disease and chronic inflammation compared to people without HIV, even when their virus is undetectable. Researchers want to know if this medication-free approach—changing what you eat—can help lower these risks and improve overall health without adding more pills.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups. If you're in the intervention group (the larger group), you'll receive personalized dietary counseling and tailored meal plans to help you adopt a Mediterranean diet, with follow-up support visits at weeks 4 and 12. If you're in the standard care group, you'll receive general dietary information. All participants will have clinical and laboratory evaluations at the start, at week 24, and at week 48 (about 11 months total). The study will measure changes in your cholesterol, inflammation markers, heart health, and how well you're following the Mediterranean diet.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Spain